Barclays lowered the firm’s price target on Acadia Healthcare (ACHC) to $20 from $28 and keeps an Equal Weight rating on the shares post the Q2 report. Despite larger than expected Tennessee payments, the company still lowered its 2025 EBITDA guidance, including a $30M core reduction due to slower volumes, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC: